Sanders Targets Health Industry Profits. Are His Figures Right?
Calculations are complicated, but correct.
Team Trump Says Administration’s Action On Health Care ‘Is Working.’ Is It?
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
Yang And Sanders Use Maternal Mortality Stats To Talk About Race
These numbers are stark.
Warren’s Argument That Millions Can’t Afford Their Rx Drugs Holds Up
‘Medication insecurity’ is a thing.
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
The pharmaceutical industry’s argument that capping drug prices would compromise drug innovation stands “on very shaky ground.”
Klobuchar Leans In On Support For Roe V. Wade, Planned Parenthood
Some of the numbers cited by the Minnesota senator during Wednesday’s Democratic presidential debate miss the mark.
Do 160 Million Americans Really Like Their Health Plans? Kind Of
Former Vice President Joe Biden’s claim during the latest Democratic presidential debate relies on a squishy number, and context matters.
Surgeon General’s Marijuana Warning Omits Crucial Context
Surgeon General Jerome Adams said the drug has a “unique impact” on the developing brain — technically true, but neglecting a vital comparison to other drugs, as well as shortcomings in the existing research.
Más dolor de cabeza para oficiales federales por la promoción del vapeo en internet
Mientras Washington se esfuerza por tomar medidas enérgicas contra la naciente industria del vapeo, los “influencers” de internet tienen su propia agenda.
A Regulatory Haze: Vape Marketers Are Online, Creating New Headaches For Feds
The subculture around vaping has been fueled by social media, and traditional regulations don’t easily address potential pitfalls.